Orient Pharma Market Cap

Orient Pharma has a market cap or net worth of 8.03 billion as of July 11, 2025. Its market cap has increased by 29.73% in one year.

Market Cap

8.03B

Enterprise Value

8.31B

Revenue

1.26B

Ranking

n/a

PE Ratio

66.67

Stock Price

36.10

Market Cap Chart

Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 8.03B, an increase of 95.07%. That is a compound annual growth rate of 5.24%.

Market Cap History

Date	Market Cap	% Change
Jul 10, 2025	8.14B	1.39%
Dec 31, 2024	8.03B	80.00%
Dec 29, 2023	4.46B	14.13%
Dec 30, 2022	3.91B	11.76%
Dec 30, 2021	3.50B	28.52%
Dec 31, 2020	2.72B	20.11%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	180.69B
PharmaEssentia	174.63B
Bora Pharmaceuticals Co., LTD.	80.78B
Lotus Pharmaceutical	56.01B
Polaris Group	29.85B
Oneness Biotech	28.03B
Center Laboratories	26.42B
TaiMed Biologics	23.90B

Market Cap Rankings